EC approves AMAG's Rienso

The European Commission approved an MAA from Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) for Rienso ferumoxytol to treat iron deficiency anemia in chronic kidney disease (CKD) patients. Takeda, which ...